z-logo
Premium
Effects of ecdysteroid agonist RH‐2485 reveal interactions between ecdysteroids and juvenile hormones in the development of Sesamia nonagrioides
Author(s) -
Eizaguirre Matilde,
López Carmen,
Schafellner Christa,
Sehnal František
Publication year - 2007
Publication title -
archives of insect biochemistry and physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.576
H-Index - 66
eISSN - 1520-6327
pISSN - 0739-4462
DOI - 10.1002/arch.20181
Subject(s) - ecdysteroid , biology , larva , instar , juvenile hormone , metamorphosis , medicine , endocrinology , pyralidae , zoology , ecology
Larvae of Sesamia nonagrioides developing under long day (LD) conditions pupate in the 5th or 6th instar, whereas under the short day (SD) conditions, they undergo several supernumerary larval molts and are regarded as diapausing. The development in early larval instars occurs in the LD larvae at a moderate and in the SD larvae at a high juvenile hormone (JH) titer; ecdysteroid titer cycles similarly under both conditions. The transformation to pupa is initiated by a burst of ecdysteroids at undetectable JH levels, whereas extra larval molts in the diapausing larvae are associated with moderate JH titer and irregular rises of ecdysteroids. Application of 0.2 ppm RH‐2485 to the diet of the 6th instar larvae promotes hormonal changes supporting metamorphosis in the LD larvae and slightly accelerates larval molts in the diapausing SD larvae. The 0.5‐ and 1‐ppm doses revert these patterns of endocrine regulations to a mode typical for early larval instars. Particularly dramatic is a JH titer increase provoked within 24 h in the LD larvae. After the treatment, both the LD and SD larvae undergo a series of larval molts, suggesting that hormonal programming of the larval development has been stabilized. A few insects receiving 1 ppm RH‐2485, and a high proportion of those fed with 5 ppm RH‐2485, deposit two cuticles within a single apolysis and die. Arch. Insect Biochem. Physiol. 65:74–84, 2007. © 2007 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here